Satellos Bioscience's total assets for Q4 2024 were C$73.02M, an increase of 201.61% from the previous quarter. MSCLF total liabilities were C$5.16M for the fiscal quarter, a 42.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.